Cargando…

Fusu mixture alleviates inflammatory reactions in lipopolysaccharide-induced acute respiratory distress syndrome mice via regulation of surfactant-associated protein C, aquaporin 5, and Notch1

BACKGROUND: Acute respiratory distress syndrome (ARDS) is a common life-threatening critical illness with high mortality. Fusu mixture (FSM) can improve the mechanical ventilation in ARDS patients. However, the detailed pharmacological mechanisms and active substances of FSM are still unclear. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Song, Yue, Yan, Liu, Jing, Zhi, Lijia, Zhang, Li, Zhang, Kaichen, Ding, Peng, Gao, Peiyang, Long, Kunlan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323576/
https://www.ncbi.nlm.nih.gov/pubmed/37426152
http://dx.doi.org/10.21037/jtd-23-367
_version_ 1785068977131618304
author Zhang, Song
Yue, Yan
Liu, Jing
Zhi, Lijia
Zhang, Li
Zhang, Kaichen
Ding, Peng
Gao, Peiyang
Long, Kunlan
author_facet Zhang, Song
Yue, Yan
Liu, Jing
Zhi, Lijia
Zhang, Li
Zhang, Kaichen
Ding, Peng
Gao, Peiyang
Long, Kunlan
author_sort Zhang, Song
collection PubMed
description BACKGROUND: Acute respiratory distress syndrome (ARDS) is a common life-threatening critical illness with high mortality. Fusu mixture (FSM) can improve the mechanical ventilation in ARDS patients. However, the detailed pharmacological mechanisms and active substances of FSM are still unclear. This study aimed to explore the potential pharmacological mechanisms of FSM for treating ARDS and its chemical compositions. METHODS: A lipopolysaccharide (LPS)-induced ARDS mouse model was established, and the mice subsequently received FSM (50 mg/kg) orally for 5 days. Then, the blood samples and lung tissues were collected. Enzyme-linked immunosorbent assay (ELISA) was used to determine the levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in serum, and histopathology examinations were applied to analyze the inflammatory response of lung tissues in ARDS mice. In addition, protein expressions of aquaporin 5 (AQP-5), surfactant-associated protein C (SP-C), and Notch1 were detected by western blot assays and immunohistochemical (IHC) examination. In addition, the chemical compositions of FSM were analyzed by high performance liquid chromatography (HPLC), using standard reference agents. RESULTS: After LPS induction, the serum levels of IL-6 and TNF-α in ARDS mice were significantly increased (P<0.01, vs. Control), and FSM significantly reduced these 2 pro-inflammatory cytokines (IL-6 and TNF-α) compared to the model mice (P<0.01). Histopathology examinations showed FSM significantly attenuated the inflammatory responses in lung tissues. Furthermore, after FSM treatment, the SP-C and AQP-5 were significantly increased, compared to the Model mice (P<0.01), and FSM also up-regulated the Notch1 expressions in lung tissues of ARDS mice (P<0.001, vs. Model). CONCLUSIONS: Collectively, it is suggested that FSM alleviates inflammatory reactions and promotes the proliferation of alveolar epithelial cells in LPS-induced ARDS mice via regulation of SP-C, AQP-5, and Notch1 in lung tissues.
format Online
Article
Text
id pubmed-10323576
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-103235762023-07-07 Fusu mixture alleviates inflammatory reactions in lipopolysaccharide-induced acute respiratory distress syndrome mice via regulation of surfactant-associated protein C, aquaporin 5, and Notch1 Zhang, Song Yue, Yan Liu, Jing Zhi, Lijia Zhang, Li Zhang, Kaichen Ding, Peng Gao, Peiyang Long, Kunlan J Thorac Dis Original Article BACKGROUND: Acute respiratory distress syndrome (ARDS) is a common life-threatening critical illness with high mortality. Fusu mixture (FSM) can improve the mechanical ventilation in ARDS patients. However, the detailed pharmacological mechanisms and active substances of FSM are still unclear. This study aimed to explore the potential pharmacological mechanisms of FSM for treating ARDS and its chemical compositions. METHODS: A lipopolysaccharide (LPS)-induced ARDS mouse model was established, and the mice subsequently received FSM (50 mg/kg) orally for 5 days. Then, the blood samples and lung tissues were collected. Enzyme-linked immunosorbent assay (ELISA) was used to determine the levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in serum, and histopathology examinations were applied to analyze the inflammatory response of lung tissues in ARDS mice. In addition, protein expressions of aquaporin 5 (AQP-5), surfactant-associated protein C (SP-C), and Notch1 were detected by western blot assays and immunohistochemical (IHC) examination. In addition, the chemical compositions of FSM were analyzed by high performance liquid chromatography (HPLC), using standard reference agents. RESULTS: After LPS induction, the serum levels of IL-6 and TNF-α in ARDS mice were significantly increased (P<0.01, vs. Control), and FSM significantly reduced these 2 pro-inflammatory cytokines (IL-6 and TNF-α) compared to the model mice (P<0.01). Histopathology examinations showed FSM significantly attenuated the inflammatory responses in lung tissues. Furthermore, after FSM treatment, the SP-C and AQP-5 were significantly increased, compared to the Model mice (P<0.01), and FSM also up-regulated the Notch1 expressions in lung tissues of ARDS mice (P<0.001, vs. Model). CONCLUSIONS: Collectively, it is suggested that FSM alleviates inflammatory reactions and promotes the proliferation of alveolar epithelial cells in LPS-induced ARDS mice via regulation of SP-C, AQP-5, and Notch1 in lung tissues. AME Publishing Company 2023-06-16 2023-06-30 /pmc/articles/PMC10323576/ /pubmed/37426152 http://dx.doi.org/10.21037/jtd-23-367 Text en 2023 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Zhang, Song
Yue, Yan
Liu, Jing
Zhi, Lijia
Zhang, Li
Zhang, Kaichen
Ding, Peng
Gao, Peiyang
Long, Kunlan
Fusu mixture alleviates inflammatory reactions in lipopolysaccharide-induced acute respiratory distress syndrome mice via regulation of surfactant-associated protein C, aquaporin 5, and Notch1
title Fusu mixture alleviates inflammatory reactions in lipopolysaccharide-induced acute respiratory distress syndrome mice via regulation of surfactant-associated protein C, aquaporin 5, and Notch1
title_full Fusu mixture alleviates inflammatory reactions in lipopolysaccharide-induced acute respiratory distress syndrome mice via regulation of surfactant-associated protein C, aquaporin 5, and Notch1
title_fullStr Fusu mixture alleviates inflammatory reactions in lipopolysaccharide-induced acute respiratory distress syndrome mice via regulation of surfactant-associated protein C, aquaporin 5, and Notch1
title_full_unstemmed Fusu mixture alleviates inflammatory reactions in lipopolysaccharide-induced acute respiratory distress syndrome mice via regulation of surfactant-associated protein C, aquaporin 5, and Notch1
title_short Fusu mixture alleviates inflammatory reactions in lipopolysaccharide-induced acute respiratory distress syndrome mice via regulation of surfactant-associated protein C, aquaporin 5, and Notch1
title_sort fusu mixture alleviates inflammatory reactions in lipopolysaccharide-induced acute respiratory distress syndrome mice via regulation of surfactant-associated protein c, aquaporin 5, and notch1
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323576/
https://www.ncbi.nlm.nih.gov/pubmed/37426152
http://dx.doi.org/10.21037/jtd-23-367
work_keys_str_mv AT zhangsong fusumixturealleviatesinflammatoryreactionsinlipopolysaccharideinducedacuterespiratorydistresssyndromemiceviaregulationofsurfactantassociatedproteincaquaporin5andnotch1
AT yueyan fusumixturealleviatesinflammatoryreactionsinlipopolysaccharideinducedacuterespiratorydistresssyndromemiceviaregulationofsurfactantassociatedproteincaquaporin5andnotch1
AT liujing fusumixturealleviatesinflammatoryreactionsinlipopolysaccharideinducedacuterespiratorydistresssyndromemiceviaregulationofsurfactantassociatedproteincaquaporin5andnotch1
AT zhilijia fusumixturealleviatesinflammatoryreactionsinlipopolysaccharideinducedacuterespiratorydistresssyndromemiceviaregulationofsurfactantassociatedproteincaquaporin5andnotch1
AT zhangli fusumixturealleviatesinflammatoryreactionsinlipopolysaccharideinducedacuterespiratorydistresssyndromemiceviaregulationofsurfactantassociatedproteincaquaporin5andnotch1
AT zhangkaichen fusumixturealleviatesinflammatoryreactionsinlipopolysaccharideinducedacuterespiratorydistresssyndromemiceviaregulationofsurfactantassociatedproteincaquaporin5andnotch1
AT dingpeng fusumixturealleviatesinflammatoryreactionsinlipopolysaccharideinducedacuterespiratorydistresssyndromemiceviaregulationofsurfactantassociatedproteincaquaporin5andnotch1
AT gaopeiyang fusumixturealleviatesinflammatoryreactionsinlipopolysaccharideinducedacuterespiratorydistresssyndromemiceviaregulationofsurfactantassociatedproteincaquaporin5andnotch1
AT longkunlan fusumixturealleviatesinflammatoryreactionsinlipopolysaccharideinducedacuterespiratorydistresssyndromemiceviaregulationofsurfactantassociatedproteincaquaporin5andnotch1